These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1617983)

  • 1. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study.
    Jepsen S; Herlevsen P; Knudsen P; Bud MI; Klausen NO
    Crit Care Med; 1992 Jul; 20(7):918-23. PubMed ID: 1617983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study.
    Domenighetti G; Suter PM; Schaller MD; Ritz R; Perret C
    J Crit Care; 1997 Dec; 12(4):177-82. PubMed ID: 9459113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.
    Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J
    Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study.
    Suter PM; Domenighetti G; Schaller MD; Laverrière MC; Ritz R; Perret C
    Chest; 1994 Jan; 105(1):190-4. PubMed ID: 8275731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal prostaglandin E1 in acute respiratory distress syndrome: a placebo-controlled, randomized, double-blind, multicenter clinical trial.
    Abraham E; Park YC; Covington P; Conrad SA; Schwartz M
    Crit Care Med; 1996 Jan; 24(1):10-5. PubMed ID: 8565513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group.
    Bernard GR; Wheeler AP; Arons MM; Morris PE; Paz HL; Russell JA; Wright PE
    Chest; 1997 Jul; 112(1):164-72. PubMed ID: 9228372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive beneficial effects of the prone position, nitric oxide, and almitrine bismesylate on gas exchange and oxygen transport in acute respiratory distress syndrome.
    Jolliet P; Bulpa P; Ritz M; Ricou B; Lopez J; Chevrolet JC
    Crit Care Med; 1997 May; 25(5):786-94. PubMed ID: 9187597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome.
    Vincent JL; Brase R; Santman F; Suter PM; McLuckie A; Dhainaut JF; Park Y; Karmel J
    Intensive Care Med; 2001 Oct; 27(10):1578-83. PubMed ID: 11685297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.
    Dellinger RP; Zimmerman JL; Taylor RW; Straube RC; Hauser DL; Criner GJ; Davis K; Hyers TM; Papadakos P
    Crit Care Med; 1998 Jan; 26(1):15-23. PubMed ID: 9428538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulized prostacyclin (PGI2) in acute respiratory distress syndrome: impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response.
    Domenighetti G; Stricker H; Waldispuehl B
    Crit Care Med; 2001 Jan; 29(1):57-62. PubMed ID: 11176161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial.
    Meduri GU; Headley AS; Golden E; Carson SJ; Umberger RA; Kelso T; Tolley EA
    JAMA; 1998 Jul; 280(2):159-65. PubMed ID: 9669790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine.
    Laurent T; Markert M; Feihl F; Schaller MD; Perret C
    Chest; 1996 Jan; 109(1):163-6. PubMed ID: 8549180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome.
    Yu M; Tomasa G
    Crit Care Med; 1993 Nov; 21(11):1635-42. PubMed ID: 8222677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment.
    Meduri GU; Tolley EA; Chinn A; Stentz F; Postlethwaite A
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1432-41. PubMed ID: 9817690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of different transpulmonary pressures guided mechanical ventilation on respiratory and hemodynamics of patients with ARDS: a prospective randomized controlled trial].
    Li J; Luo Z; Li X; Huang Z; Han J; Li Z; Zhou Z; Chen H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):39-44. PubMed ID: 28459402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome.
    Taher A; Lashgari M; Sedighi L; Rahimi-Bashar F; Poorolajal J; Mehrpooya M
    Pharmacol Rep; 2021 Dec; 73(6):1650-1659. PubMed ID: 34114174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled pilot randomized trial of methylprednisolone infusion in pediatric acute respiratory distress syndrome.
    Drago BB; Kimura D; Rovnaghi CR; Schwingshackl A; Rayburn M; Meduri GU; Anand KJ
    Pediatr Crit Care Med; 2015 Mar; 16(3):e74-81. PubMed ID: 25634565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sustained inflation and postinflation positive end-expiratory pressure in acute respiratory distress syndrome: focusing on pulmonary and extrapulmonary forms.
    Tugrul S; Akinci O; Ozcan PE; Ince S; Esen F; Telci L; Akpir K; Cakar N
    Crit Care Med; 2003 Mar; 31(3):738-44. PubMed ID: 12626977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of N-acetylcysteine as treatment for the adult respiratory distress syndrome.
    Bernard GR
    Eur Respir J Suppl; 1990 Oct; 11():496s-498s. PubMed ID: 2278610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome].
    Lyu G; Wang X; Jiang W; Cai T; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.